Solventum is delighted to partner with INVNNZ for the July edition of the Solventum Series with Experts. This webinar explores best practices in vascular access for high-risk patients, focusing on patient safety and improved clinical outcomes. Learn how to identify difficult venous access, apply evidence-based techniques to increase first-attempt cannulation success, minimisepatient harm, and preserve vessel health.

Kia ora, We are planning to remind you that BD PosiFlush sodium chloride 0.9% inj prefilled syringes (Becton Dickinson) will be replaced by Polyflush sodium chloride 0.9% inj prefilled syringes (Aria Healthcare).

Please join us in Christchurch at the 2026 IVNNZ conference 16th-17th October at Addington Events Centre. This will be preceded by the popular IVNNZ forum on 15th October, also at the Addington Events Centre.

The intravenous NZ is delighted to announce that Medical Specialties NZ will continue its valued partnership as Platinum Sponsor of the IVNNZ Conference. MSA is a leading medical device distribution company providing innovative technologies and clinical solutions across NZ, particularly in areas such as vascular access and minimally invasive medical devices.